Epetraborole R-Mandelate

• CAT Number: I026913
• CAS Number: 1234563-15-5
• Molecular Formula: C19H24BNO7
• Molecular Weight: 389.21
• Purity: 98%
• Synonyms: Epetraborole R-Mandelate; Epetraborole R Mandelate
• Solubility: Soluble in DMSO
• Appearance: Solid powder
• Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
• IUPAC Name: 3-[[(3S)-3-(aminomethyl)-1-hydroxy-3H-2,1-benzoxaborol-7-yl]oxy]propan-1-ol;(2R)-2-hydroxy-2-phenylacetic acid
• InChI: InChI=1S/C11H16BNO4.C8H8O3/c13-7-10-8-3-1-4-9(16-6-2-5-14)11(8)12(15)17-10;9-7(8(10)11)6-4-2-1-3-5-6/h1,3-4,10,14-15H,2,5-7,13H2;1-5,7,9H,(H,10,11)/t10-;7-/m11/s1
• InChIKey: GKQOYBLEEYTDIB-DEZAYANASA-N
• SMILES: B1(C2=C(C=CC=C2OCCCO)[C@H](O1)CN)O.C1=CC=C(C=C1)[C@H](C(=O)O)O

Epetraborole R-mandelate（Cat No.:I026913）is a chemical compound that consists of the epetraborole molecule, which is a boron-containing compound, conjugated with mandelic acid in its R-enantiomeric form. Epetraborole is primarily studied for its antimicrobial properties, particularly in targeting bacterial infections by inhibiting specific enzymes involved in bacterial cell wall synthesis. The addition of mandelate may influence the compound’s solubility, stability, and pharmacokinetics. This compound has been explored in preclinical studies for its potential therapeutic applications, particularly in the treatment of antibiotic-resistant infections, though further research is needed to evaluate its clinical effectiveness and safety.